Multiple Myeloma in Relapse Clinical Trials in Shenzhen, Guangdong
2 recruitingShenzhen, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
Multiple Myeloma in RelapseRefractory Multiple MyelomaPlasmacytoid; Lymphoma
iCell Gene Therapeutics12 enrolled2 locationsNCT04162353
Recruiting
Phase 1Phase 2
BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
Multiple Myeloma in Relapse
Shenzhen University General Hospital10 enrolled1 locationNCT06644443